Review
Copyright ©The Author(s) 2025.
World J Psychiatry. Aug 19, 2025; 15(8): 107885
Published online Aug 19, 2025. doi: 10.5498/wjp.v15.i8.107885
Table 2 Key psychosocial mediating variables influencing treatment adherence in people living with human immunodeficiency virus
Mediating variable
Definition
Mediating mechanism
Key findings
Ref.
StigmaSocial stigma and self-stigmatization related to HIVAffects access to health information and self-efficacy through external and internal stigma pathwaysStigma leads to avoidance of medication information and increased risk of dosage errors; internalized stigma is significantly associated with psychological inflexibility[21,22]
Self-efficacyPatients’ belief in their ability to successfully perform treatment behaviorsPromotes translation of health knowledge into treatment behaviors via the self-regulatory system in social cognitive theoryHigher self-efficacy is significantly associated with better adherence; treatment success reinforces efficacy, forming a positive feedback loop[31,32]
Social supportSupport from peers, family, and healthcare providersProvides emotional and informational support, buffers stigma, and enhances self-efficacyPeer support is strongly linked to long-term retention, adherence, and viral suppression; family support buffers the negative impact of low medication literacy on adherence[52,53]
Depression/anxietyMental health problems associated with HIVAlters cognitive processing through functional decoupling of the prefrontal–limbic systemDepression reduces glucose metabolism in the prefrontal cortex, impairing working memory and executive function; anxiety heightens amygdala–insula reactivity, leading to cognitive overload[58-61]
Patient–provider trustDegree of trust patients have in healthcare providersEnhances the therapeutic alliance and reduces suspicion and fear of the medical systemLower levels of trust are linked to poorer adherence and outcomes; especially relevant among minority populations[89]